Medicine

Projects

Projects per year 1975 1989 2002 2005 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2025

• 25 Not started
• 128 Active
• 802 Finished

Projects per year

Search results

• Targeting intracellular calcium leak as novel therapy for diabetes

  Santulli, G.

  National Institute of Diabetes and Digestive and Kidney Diseases

  12/1/17 → 11/30/20

  Project: Research project

  • Ryanodine Receptor Calcium Release Channel 100%
  • Type 2 Diabetes Mellitus 60%
  • Calcium 47%
  • Polymorphic catecholergic ventricular tachycardia 42%
  • Glucose 33%

• Targeting intracellular calcium leak as novel therapy for diabetes

  Santulli, G.

  9/14/15 → 11/30/20

  Project: Research project

  • Ryanodine Receptor Calcium Release Channel 100%
  • Type 2 Diabetes Mellitus 60%
  • Polymorphic catecholergic ventricular tachycardia 42%
  • Glucose 33%
  • Mentors 33%

• TAS:: 75 0850 ::TAS RECOVERY ACT - ACTNOW CLINICAL TRIAL 8376

  Sparano, J. A.

  Project: Research project

  • National Cancer Institute (U.S.) 100%
  • Clinical Trials 56%
  • Contracts 43%
  • TimeLine 32%
  • Neoplasms 23%

• TAXOL--MECHANISMS OF ACTION AND RESISTANCE

  Band Horwitz, S., Smith, A., McDaid, H. M., Band Horwitz, S., McDaid, H. M., Band Horwitz, S., McDaid, H. M., McDaid, H. M., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A., Rose, S. A. & Band Horwitz, S.

  6/1/98 → 6/30/21

  Project: Research project

  • paclitaxel 100%
  • microtubules 25%
  • tubulin 20%
  • mechanism of action 17%
  • drugs 13%

• TestED!: Applying Implementation Science to improve an HIV testing strategy for Emergency Departments

  Felsen, U. R.

  National Institute of Mental Health

  9/21/15 → 8/31/21

  Project: Research project

  • Implementation Science 100%
  • Hospital Emergency Service 55%
  • HIV 50%
  • Vulnerable Populations 16%
  • Research Personnel 11%

• TestED!: Applying Implementation Science to improve an HIV testing strategy for Emergency Departments

  Felsen, U. R.

  9/21/15 → 8/31/21

  Project: Research project

  • HIV 100%
  • Hospital Emergency Service 69%
  • Implementation Science 66%
  • Vulnerable Populations 30%
  • Research Personnel 20%

• Th2A cells mediate outcomes of aspirin-exacerbated respiratory disease

  Jerschow, E.

  9/3/20 → 8/31/21

  Project: Research project

  • Aspirin 100%
  • Th2 Cells 66%
  • Prostaglandin D2 62%
  • Nasal Polyps 30%
  • prostaglandin R2 D-isomerase 14%

• Th2A cells mediate outcomes of aspirin-exacerbated respiratory disease

  Jerschow, E.

  National Institute of Allergy and Infectious Diseases

  9/3/20 → 8/31/22

  Project: Research project

  • Th2 Cells 100%
  • Aspirin 92%
  • Prostaglandin D2 60%
  • Nasal Polyps 29%
  • prostaglandin R2 D-isomerase 14%

• The Center of Excellence in Promoting LHS Operations and Research at Einstein/Montefiore (EXPLORE)

  Cunningham, C. O., Marantz, P. R. & Rinke, M. L.

  9/30/18 → 9/29/23

  Project: Research project

  • infrastructure 100%
  • health 97%
  • health care 51%
  • resources 46%
  • leader 45%

• The Fat1 Cadherin and Vascular Remodeling

  Sibinga, N. E. S.

  National Heart, Lung, and Blood Institute

  7/1/08 → 6/30/13

  Project: Research project

  • Vascular Remodeling 100%
  • Cadherins 72%
  • Vascular Smooth Muscle 50%
  • Vascular Diseases 50%
  • Smooth Muscle Myocytes 45%

• The Fat1 Cadherin and Vascular Remodeling

  Sibinga, N. E. S. & Rose, S. A.

  7/1/08 → 6/30/13

  Project: Research project

  • Vascular Remodeling 100%
  • Vascular Smooth Muscle 46%
  • Vascular Diseases 45%
  • Smooth Muscle Myocytes 41%
  • Cell Movement 23%

• The Fat1 Cadherin in Atherosclerotic Vascular Disease

  Sibinga, N. E. S., Rose, S. A. & Rose, S. A.

  4/1/11 → 2/29/16

  Project: Research project

  • Vascular Smooth Muscle 100%
  • Smooth Muscle Myocytes 89%
  • Vascular Diseases 82%
  • Vascular Remodeling 59%
  • Cell Nucleus 34%

• The Fat1 Cadherin in Atherosclerotic Vascular Disease

  Sibinga, N. E. S.

  National Heart, Lung, and Blood Institute

  4/1/11 → 8/31/15

  Project: Research project

  • Vascular Smooth Muscle 100%
  • Vascular Diseases 92%
  • Smooth Muscle Myocytes 89%
  • Cadherins 89%
  • Vascular Remodeling 59%

• The impact of HIV on accelerated aging in the female genital tract: a pilot trial of topical estradiol to improve the vaginal microbiome and symptoms of vaginal atrophy in menopausal women with HIV

  Murphy, K. J.

  2/1/20 → 1/31/22

  Project: Research project

  • HIV 100%
  • Female Genitalia 57%
  • Dysbiosis 51%
  • Microbiota 47%
  • Inflammation 24%

• The impact of HIV on accelerated aging in the female genital tract: a pilot trial of topical estradiol to improve the vaginal microbiome and symptoms of vaginal atrophy in menopausal women with HIV

  Murphy, K. J.

  National Institute on Aging

  2/1/20 → 1/31/23

  Project: Research project

  • Female Genitalia 100%
  • Microbiota 82%
  • Atrophy 69%
  • HIV 69%
  • Estradiol 68%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 51%
  • drug therapy 8%
  • Schools of medicine 6%
  • action plan 6%

• The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease

  Broder, A. R.

  7/1/17 → 6/30/22

  Project: Research project

  • end stage renal disease 100%
  • mortality 27%
  • drug therapy 7%
  • Schools of medicine 6%
  • action plan 5%

• The impact of medical cannabis on pain and inflammation in people living with HIV

  Slawek, D. E.

  National Institute on Drug Abuse

  7/15/21 → 6/30/22

  Project: Research project

  • Medical Marijuana 100%
  • HIV 41%
  • Pain 26%
  • Neuralgia 25%
  • Inflammation 25%

• THE MECHANISM OF BILE PIGMENT EXCRETION

  Roy-Chowdhury, J.

  2/1/82 → 1/31/87

  Project: Research project

• The Mediator complex in the coordinate regulation of lipogenic gene expression

  Pessin, J. E. & Yang, F.

  6/15/16 → 4/30/21

  Project: Research project

  • DNA-directed RNA polymerase 100%
  • insulin resistance 89%
  • liver 71%
  • phosphotransferases (kinases) 62%
  • gene expression 59%

• The Neural Underpinnings of Depression and Cannabis Use in Young PLWH

  Gabbay, V., Sharma, A. & Starrels, J. L.

  National Institute on Drug Abuse

  9/1/21 → 7/31/22

  Project: Research project

  • Reward 100%
  • Cannabis 95%
  • Habenula 57%
  • Depression 54%
  • Pain 47%

• The Neuroimmunology of Depression in Women Living With HIV

  Gabbay, V. & Sharma, A.

  NATIONAL INSTITUTE OF MENTAL HEALTH

  9/16/21 → 6/30/22

  Project: Research project

  • Reward 100%
  • HIV 92%
  • Depression 79%
  • Anhedonia 57%
  • Kynurenine 46%

• The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia

  Gritsman, K.

  9/15/10 → 8/31/15

  Project: Research project

  • Phosphatidylinositol 3-Kinases 100%
  • Leukemia 49%
  • Hematopoietic Stem Cells 40%
  • fms-Like Tyrosine Kinase 3 33%
  • Acute Myeloid Leukemia 28%

• The p110 alpha and delta isoforms of PI3 kinase in hematopoiesis and leukemia

  Gritsman, K.

  National Cancer Institute

  9/15/10 → 8/31/15

  Project: Research project

  • Phosphatidylinositol 3-Kinases 100%
  • Hematopoiesis 96%
  • Leukemia 77%
  • Protein Isoforms 71%
  • Hematopoietic Stem Cells 42%

• Therapeutic targeting of glutamine metabolism in MDS

  Verma, A. K. & Verma, A. K.

  4/1/16 → 3/31/21

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • Glutaminase 64%
  • Glutamine 39%
  • CB-839 38%
  • Neoplasms 12%

• Therapeutic targeting of MDS stem cells

  Steidl, U. G., Verma, A. K., Steidl, U. G. & Verma, A. K.

  National Heart, Lung, and Blood Institute

  8/20/18 → 6/30/22

  Project: Research project

  • Interleukin-8 100%
  • Stem Cells 71%
  • Heterografts 17%
  • Disease Progression 15%
  • Therapeutics 15%

• Therapeutic targeting of MDS stem cells

  Steidl, U. G. & Verma, A. K.

  8/20/18 → 6/30/22

  Project: Research project

  • Interleukin-8 100%
  • Stem Cells 42%
  • Heterografts 17%
  • Disease Progression 15%
  • Interleukin-8 Receptors 14%

• Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes

  Verma, A. K. & Verma, A. K.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/14 → 5/31/18

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • MicroRNAs 63%
  • Hematopoiesis 15%
  • Stem Cells 13%
  • Bone Marrow Failure Disorders 12%

• Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes

  Verma, A. K. & Verma, A. K.

  9/1/14 → 5/31/18

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • Hematopoiesis 14%
  • Stem Cells 13%
  • Bone Marrow Failure Disorders 12%
  • In Vitro Techniques 9%

• THE RED CELL CYTOSKELETON AND SICKLE CELL DISEASE

  Bouhassira, E. E., Lutty, G. A., Kaul, D., Acharya, S. A., Croizat, H., Fabry, M., Schwartz, R., Benjamin, L., Nagel, R., Kaul, D., Croizat, H., Fabry, M., Schwartz, R., Benjamin, L. & Nagel, R.

  1/1/01 → 9/30/03

  Project: Research project

  • Sickle Hemoglobin 100%
  • Proteins 59%
  • Spectrin 47%
  • Sickle Cell Anemia 39%
  • Cytoskeleton 35%

• The Renal Pathogenicity of anti-DNA Antibodies

  Putterman, C.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/12/02 → 6/30/15

  Project: Research project

  • Antinuclear Antibodies 100%
  • Actinin 78%
  • Virulence 71%
  • Kidney 48%
  • Lupus Nephritis 38%

• The Renal Pathogenicity of Anti-DNA Antibodies

  Putterman, C.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  7/10/08 → 6/30/09

  Project: Research project

  • Antinuclear Antibodies 100%
  • Actinin 92%
  • Lupus Nephritis 68%
  • Kidney 57%
  • Antibodies 56%

• The role of APOL1 polymorphisms in promoting HIV-related kidney injury

  Ross, M. J.

  9/25/15 → 6/30/21

  Project: Research project

  • Apolipoprotein L1 100%
  • Kidney 28%
  • Alleles 26%
  • HIV 25%
  • HIV Infections 18%

• The role of APOL1 polymorphisms in promoting HIV-related kidney injury

  Ross, M. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/25/15 → 6/30/21

  Project: Research project

  • Apolipoprotein L1 100%
  • HIV 37%
  • Kidney 30%
  • Wounds and Injuries 25%
  • Alleles 25%

• The role of Dock4 in normal and aberrant erythropoiesis

  Verma, A. K., Wickrema, A., Verma, A. K., Rose, S. A., Rose, S. A., Rose, S. A. & Rose, S. A.

  9/26/12 → 6/30/17

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • Erythropoiesis 82%
  • Erythroblasts 57%
  • Anemia 29%
  • Reticulocytes 21%

• The role of Dock4 in normal and aberrant erythropoiesis

  Verma, A. K. & Wickrema, A.

  National Heart, Lung, and Blood Institute

  9/26/12 → 6/30/17

  Project: Research project

  • Myelodysplastic Syndromes 100%
  • Erythropoiesis 99%
  • Erythroblasts 57%
  • Anemia 29%
  • Reticulocytes 21%

• The Role of Dysfunctional CCK-1R in Cholelithogenesis

  Wang, D. Q. H. & Rose, S. A.

  1/15/08 → 12/31/12

  Project: Research project

  • cholelithiasis 100%
  • cholecystokinin 80%
  • gall bladder 57%
  • mice 51%
  • receptors 48%

• The role of FAT10 in the pathogenesis of HIV-associated nephropathy

  Ross, M. J. & Rose, S. A.

  8/15/07 → 7/31/13

  Project: Research project

  • AIDS-Associated Nephropathy 100%
  • Epithelial Cells 40%
  • Kidney 39%
  • Apoptosis 20%
  • HIV Infections 14%

• THE ROLE OF GLUCOSAMINE PATHWAY IN NUTRITIONALLY-MEDIATE

  Hawkins, M. A.

  9/1/00 → 8/31/01

  Project: Research project

  • Insulin Resistance 100%
  • Nutrients 78%
  • Glucosamine 37%
  • Gene Expression 27%
  • Sp Transcription Factors 26%

• The role of SEPT9_v1 in mammary tumorigenesis

  Peterson, E. A.

  National Institutes of Health

  11/16/07 → 11/15/09

  Project: Research project

  • Breast 100%
  • Carcinogenesis 95%
  • Cytokinesis 89%
  • Aneuploidy 80%
  • Tubulin 80%

• The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric

  Putterman, C.

  9/1/14 → 8/31/20

  Project: Research project

  • Systemic Lupus Erythematosus 100%
  • Autoantibodies 98%
  • Cytokines 87%
  • TWEAK Receptor 62%
  • Central Nervous System Lupus Vasculitis 55%

• The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric

  Putterman, C.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/1/14 → 8/31/20

  Project: Research project

  • Systemic Lupus Erythematosus 100%
  • Autoantibodies 98%
  • Cytokines 87%
  • TWEAK Receptor 62%
  • Central Nervous System Lupus Vasculitis 55%

• The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis

  Chan, J., TORRELLES, J. & Chan, J.

  National Institute of Allergy and Infectious Diseases

  1/16/20 → 12/31/22

  Project: Research project

  • Mycobacterium tuberculosis 100%
  • Tuberculosis 84%
  • phosphatidylinositol mannoside 76%
  • Growth 24%
  • Cell Wall 20%

• The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis

  Chan, J.

  1/16/20 → 12/31/21

  Project: Research project

  • phosphatidylinositol mannoside 100%
  • Mycobacterium tuberculosis 86%
  • Cell Wall 26%
  • Tuberculosis 21%
  • Growth 21%

• The System Biology of Sudden Cardiac Death

  Tomaselli, G. F. & Rose, S. A.

  9/1/07 → 8/31/12

  Project: Research project

  • Sudden Cardiac Death 100%
  • Cardiac Arrhythmias 66%
  • Implantable Defibrillators 45%
  • Myocardium 32%
  • Physiological Stress 31%

• Thiamine as a Renal Protective Agent in Septic Shock

  Moskowitz, A. L.

  National Institute of General Medical Sciences

  6/1/18 → 5/31/22

  Project: Research project

  • Renal Agents 100%
  • Thiamine 89%
  • Protective Agents 81%
  • Septic Shock 70%
  • Sepsis 29%

• Thiamine as a Renal Protective Agent in Septic Shock

  Moskowitz, A. L.

  6/1/18 → 5/31/22

  Project: Research project

  • Thiamine 100%
  • Septic Shock 51%
  • Sepsis 30%
  • Thiamine Deficiency 27%
  • Kidney 23%

• Thrombophilia In Cryptogenic Stroke (THICK) Study

  Kizer, J.

  9/1/02 → 8/31/09

  Project: Research project

  • Patent Foramen Ovale 100%
  • Stroke 93%
  • Public Health 32%
  • Virulence 26%
  • Research Support 23%

• Thyroglobulin Peptide Presentation by HLA-DR in Thyroiditis

  Tomer, Y., Rose, S. A. & Rose, S. A.

  3/1/06 → 4/30/22

  Project: Research project

  • Thyroid Diseases 100%
  • Autoimmune Diseases 83%
  • Thyroglobulin 53%
  • Autoimmune Thyroiditis 49%
  • HLA-DR Antigens 48%

• Thyroid Derived Peptide Presentation by HLA-DR in Thyroiditis

  Tomer, Y.

  National Institute of Diabetes and Digestive and Kidney Diseases

  3/1/06 → 4/30/22

  Project: Research project

  • Thyroiditis 100%
  • HLA-DR Antigens 81%
  • Thyroid Diseases 72%
  • Autoimmune Diseases 58%
  • Peptides 49%